Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2012

01-06-2012 | Original Article

Promoter Polymorphism of the EED Gene Is Associated with the Susceptibility to Ulcerative Colitis

Authors: Ji-In Yu, In-Hong Kang, Geom-Seog Seo, Suck-Chei Choi, Ki-Jung Yun, Soo-Cheon Chae

Published in: Digestive Diseases and Sciences | Issue 6/2012

Login to get access

Abstract

Background

Embryonic ectoderm development (EED) protein is involved in multiple cellular protein complexes. EED mediates the repression of gene activity through histone deacetylation, and it may act as a specific regulator of integrin’s function. This gene was identified as a candidate gene for the susceptibility to IBD by our previous cDNA microarray analysis.

Aim

The present study aimed to validate the expression level of the EED gene in patients with IBD by performing RT-PCR, and we investigated whether the polymorphisms in the EED gene are associated with the susceptibility to UC, and whether a functional EED promoter polymorphism is related to UC.

Methods

Genotype analysis of the EED SNPs was performed by single-base extension analysis. The haplotype frequencies of the EED gene for multiple loci were estimated using the expectation maximization algorithm. The promoter region of the human EED gene, including the g.-1850G>C allele, was isolated by PCR. The amplified PCR products were inserted into the pGL3-basic vector and the luciferase activity was analyzed.

Results

The expression level of the EED gene was significantly decreased in both the UC and CD patients and it was significantly higher in the liver and ileum than in the other tissues of the human digestive system. The genotype and allele frequencies of the g.-1850G>C polymorphism of the EED gene in the UC patients were significantly different from those of the healthy controls (p = 0.018 and 0.017, respectively). The luciferase activity assay showed that the promoter activity was decreased about twofold in the construct containing the g.-1850G allele compared to that of the construct containing the g.-1850C allele, which means that the allele G could produce less EED mRNA.

Conclusions

These results suggest that the g.-1850G>C polymorphism in the EED gene might be associated with the susceptibility to UC by the change of the EED expression level.
Literature
1.
go back to reference Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182–205.PubMedCrossRef Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182–205.PubMedCrossRef
3.
go back to reference Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol. 1999;11:648–656.PubMedCrossRef Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol. 1999;11:648–656.PubMedCrossRef
4.
go back to reference Travis S, Jewell DP. Ulcerative colitis: clinical presentation and diagnosis. In: Satsangi J, Sutherland LR, eds. Ciclosporin Use in Acute Ulcerative Colitis: A Long-Term Experience. New York: Churchill Livingstone; 2003:169–182. Travis S, Jewell DP. Ulcerative colitis: clinical presentation and diagnosis. In: Satsangi J, Sutherland LR, eds. Ciclosporin Use in Acute Ulcerative Colitis: A Long-Term Experience. New York: Churchill Livingstone; 2003:169–182.
5.
go back to reference Forbes A. Clinical presentation and diagnosis of Crohn’s disease. In: Satsangi J, Sutherland LR, eds. Fistulating anal Crohn’s Disease: Results of Combined Surgical and Infliximab Treatment. New York: Churchill Livingstone; 2003:183–189. Forbes A. Clinical presentation and diagnosis of Crohn’s disease. In: Satsangi J, Sutherland LR, eds. Fistulating anal Crohn’s Disease: Results of Combined Surgical and Infliximab Treatment. New York: Churchill Livingstone; 2003:183–189.
6.
go back to reference Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, et al. Disparate CD4+ lamina propria (LP) lymphocyte secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN gamma, whereas, ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol. 1996;157:1261–1270.PubMed Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, et al. Disparate CD4+ lamina propria (LP) lymphocyte secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN gamma, whereas, ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol. 1996;157:1261–1270.PubMed
7.
go back to reference Ahmad T, Tamboli CP, Jewell D, Colombel JF. Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology. 2004;126:1533–1549.PubMedCrossRef Ahmad T, Tamboli CP, Jewell D, Colombel JF. Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology. 2004;126:1533–1549.PubMedCrossRef
8.
go back to reference Cavanaugh J. International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn’s disease and chromosome 16. Am J Hum Genet. 2001;68:1165–1171.PubMedCrossRef Cavanaugh J. International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn’s disease and chromosome 16. Am J Hum Genet. 2001;68:1165–1171.PubMedCrossRef
9.
go back to reference Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, et al. Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature. 1996;379:821–823.PubMedCrossRef Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, et al. Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature. 1996;379:821–823.PubMedCrossRef
10.
go back to reference Parkes M, Barmada MM, Satsangi J, Weeks DE, Jewell DP, et al. The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn’s disease. Am J Hum Genet. 2000;7:1605–1610.CrossRef Parkes M, Barmada MM, Satsangi J, Weeks DE, Jewell DP, et al. The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn’s disease. Am J Hum Genet. 2000;7:1605–1610.CrossRef
11.
go back to reference Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, et al. Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet. 1999;65:1647–1655.PubMedCrossRef Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, et al. Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet. 1999;65:1647–1655.PubMedCrossRef
12.
go back to reference van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, Lewis CM. Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet. 2004;13:763–770.PubMedCrossRef van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, Lewis CM. Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet. 2004;13:763–770.PubMedCrossRef
13.
go back to reference Schumacher A, Lichtarge O, Schwartz S, Magnusson T. The murine Polycomb-group EED and its human orthologue: functional implications of evolutionary conservation. Genomics. 1998;54:79–88.PubMedCrossRef Schumacher A, Lichtarge O, Schwartz S, Magnusson T. The murine Polycomb-group EED and its human orthologue: functional implications of evolutionary conservation. Genomics. 1998;54:79–88.PubMedCrossRef
14.
go back to reference Sewalt RGAB, van der Vlag J, Gunster MJ, Hamer KM, den Blaauwen JL, et al. Characterization of interactions between the mammalian Polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian Polycomb-group protein complexes. Mol Cell Biol. 1998;18:3586–3595.PubMed Sewalt RGAB, van der Vlag J, Gunster MJ, Hamer KM, den Blaauwen JL, et al. Characterization of interactions between the mammalian Polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian Polycomb-group protein complexes. Mol Cell Biol. 1998;18:3586–3595.PubMed
15.
go back to reference Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature. 2006;441:349–353.PubMedCrossRef Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature. 2006;441:349–353.PubMedCrossRef
16.
go back to reference Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. Genomewide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 2006;20:1123–1136.PubMedCrossRef Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. Genomewide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 2006;20:1123–1136.PubMedCrossRef
17.
go back to reference Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell. 2006;125:301–313.PubMedCrossRef Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell. 2006;125:301–313.PubMedCrossRef
18.
go back to reference Crowe DT, Chiu H, Fong S, Weissmann IL. Regulation of the avidity of integrin alpha4 beta7 by the beta7 cytoplasmic domain. J Biol Chem. 1994;269:14411–14418.PubMed Crowe DT, Chiu H, Fong S, Weissmann IL. Regulation of the avidity of integrin alpha4 beta7 by the beta7 cytoplasmic domain. J Biol Chem. 1994;269:14411–14418.PubMed
19.
go back to reference Peytavi R, Hong SS, Gay B, d’Angeac AD, Selig L, et al. H-EED, the product of the human homolog of the murine EED gene, binds to the matrix protein of HIV-1. J Biol Chem. 1999;274:1635–1645.PubMedCrossRef Peytavi R, Hong SS, Gay B, d’Angeac AD, Selig L, et al. H-EED, the product of the human homolog of the murine EED gene, binds to the matrix protein of HIV-1. J Biol Chem. 1999;274:1635–1645.PubMedCrossRef
20.
go back to reference Violot S, Hong SS, Rakotobe D, Petit C, Gay B, et al. The human Polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1. J Virol. 2003;77:12507–12522.PubMedCrossRef Violot S, Hong SS, Rakotobe D, Petit C, Gay B, et al. The human Polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1. J Virol. 2003;77:12507–12522.PubMedCrossRef
21.
go back to reference Witte V, Laffert B, Rosorius O, Lischka P, Blume K, et al. HIV-1 Nef mimics an integrin receptor signal that recruits the Polycomb group protein EED to the plasma membrane. Mol Cell. 2004;13:179–190.PubMedCrossRef Witte V, Laffert B, Rosorius O, Lischka P, Blume K, et al. HIV-1 Nef mimics an integrin receptor signal that recruits the Polycomb group protein EED to the plasma membrane. Mol Cell. 2004;13:179–190.PubMedCrossRef
22.
go back to reference Otte AP, Kwaks THJ. Gene repression by Polycomb group protein complexes: a distinct complex for every occasion? Curr Opin Genet Dev. 2003;13:448–454.PubMedCrossRef Otte AP, Kwaks THJ. Gene repression by Polycomb group protein complexes: a distinct complex for every occasion? Curr Opin Genet Dev. 2003;13:448–454.PubMedCrossRef
23.
go back to reference Kirmizis A, Bartley SM, Kuzmichev A, Margueron R, Reinberg D, et al. Silencing of human Polycomb target genes is associated with methylation of histone H3 Lys27. Genes Dev. 2004;18:1592–1605.PubMedCrossRef Kirmizis A, Bartley SM, Kuzmichev A, Margueron R, Reinberg D, et al. Silencing of human Polycomb target genes is associated with methylation of histone H3 Lys27. Genes Dev. 2004;18:1592–1605.PubMedCrossRef
24.
go back to reference Kuzmichev A, Jenuwein T, Tempst P, Reinberg D. Different Ezh2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol Cell. 2004;14:183–193.PubMedCrossRef Kuzmichev A, Jenuwein T, Tempst P, Reinberg D. Different Ezh2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol Cell. 2004;14:183–193.PubMedCrossRef
25.
go back to reference Cao R, Zhang Y. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EEDEZH2 complex. Mol Cell. 2004;15:57–67.PubMedCrossRef Cao R, Zhang Y. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EEDEZH2 complex. Mol Cell. 2004;15:57–67.PubMedCrossRef
26.
go back to reference Rakotobe D, Violot S, Hong SS, Gouet P, Boulanger P. Mapping of immunogenic and protein-interacting regions at the surface of the seven-bladed beta-propeller domain of the HIV-1 cellular interactor EED. Virol J. 2008;27:5–32. Rakotobe D, Violot S, Hong SS, Gouet P, Boulanger P. Mapping of immunogenic and protein-interacting regions at the surface of the seven-bladed beta-propeller domain of the HIV-1 cellular interactor EED. Virol J. 2008;27:5–32.
27.
go back to reference Rakotobe D, Tardy JC, André P, Hong SS, Darlix JL, et al. Human Polycomb group EED protein negatively affects HIV-1 assembly and release. Retrovirology. 2007;4:4–37.CrossRef Rakotobe D, Tardy JC, André P, Hong SS, Darlix JL, et al. Human Polycomb group EED protein negatively affects HIV-1 assembly and release. Retrovirology. 2007;4:4–37.CrossRef
28.
go back to reference Chae SC, Yu JI, Oh GJ, Choi CS, Choi SC, et al. Identification of single nucleotide polymorphisms in the TNFRSF17 gene and their association with gastrointestinal disorders. Mol Cell. 2010;29:21–28.CrossRef Chae SC, Yu JI, Oh GJ, Choi CS, Choi SC, et al. Identification of single nucleotide polymorphisms in the TNFRSF17 gene and their association with gastrointestinal disorders. Mol Cell. 2010;29:21–28.CrossRef
29.
go back to reference Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn’s disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet. 2001;10:445–456.PubMedCrossRef Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn’s disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet. 2001;10:445–456.PubMedCrossRef
30.
go back to reference Warner EE, Dieckgraefe BK. Application of genome-wide gene expression profiling by high-density DNA arrays to the treatment and study of inflammatory bowel disease. Inflamm Bowel Dis. 2002;8:140–157.PubMedCrossRef Warner EE, Dieckgraefe BK. Application of genome-wide gene expression profiling by high-density DNA arrays to the treatment and study of inflammatory bowel disease. Inflamm Bowel Dis. 2002;8:140–157.PubMedCrossRef
31.
go back to reference Park YR, Choi SC, Lee ST, Kim KS, Chae SC, et al. The association of eotaxin-2 and eotaxin-3 gene polymorphisms in a Korean population with ulcerative colitis. Exp Mol Med. 2005;37:553–558.PubMed Park YR, Choi SC, Lee ST, Kim KS, Chae SC, et al. The association of eotaxin-2 and eotaxin-3 gene polymorphisms in a Korean population with ulcerative colitis. Exp Mol Med. 2005;37:553–558.PubMed
32.
go back to reference Li CS, Zhang Q, Lee KJ, Cho SW, Lee KM, et al. Interleukin 27 polymorphisms are associated with inflammatory bowel diseases in a Korean population. J Gastroenterol Hapatol. 2009;24:1692–1696.CrossRef Li CS, Zhang Q, Lee KJ, Cho SW, Lee KM, et al. Interleukin 27 polymorphisms are associated with inflammatory bowel diseases in a Korean population. J Gastroenterol Hapatol. 2009;24:1692–1696.CrossRef
Metadata
Title
Promoter Polymorphism of the EED Gene Is Associated with the Susceptibility to Ulcerative Colitis
Authors
Ji-In Yu
In-Hong Kang
Geom-Seog Seo
Suck-Chei Choi
Ki-Jung Yun
Soo-Cheon Chae
Publication date
01-06-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2045-3

Other articles of this Issue 6/2012

Digestive Diseases and Sciences 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.